EACR25 will bring together the cancer research community alongside world-class invited speakers to discuss the most innovative current research topics, interact and form new collaborations.
The Congress will offer many opportunities for you to meet and discuss with your target audience, raise your profile among the cancer research community and showcase the latest solutions you offer. Partnership and support from companies, charities and foundations are invaluable to the success of the EACR Congress.
> 1,800 basic, preclinical and translational researchers across the full breadth of research fields
> 75% of delegates at EACR24 were from Europe, 8% from Asia, 7% from the Americas and the remaining 10% from the Middle East, Australia and Africa
> 98% would recommend the Congress to a colleague!
Have a look at the NEW sponsoring opportunities we have introduced:
> Exhibitor Spotlight
> Seating cubes
> Coffee breaks and lunches available
IMPORTANT - A successful application made by a company wishing to participate at the 25th Biennial Congress of the European Association for Cancer Research implies full acceptance of the requirements and policies contained within this document as well as the technical specifications in the forthcoming Exhibitor Service Manual – to be published online on the Congress website: eacr25.org as of February 2018.
In the past we have been made aware of accommodation service providers contacting EACR exhibitors offering accommodation for the dates of the Congress. They may claim to be part of the 'official Congress housing unit'. Please note that the EACR has no agreement or affiliation with these providers and we recommend that companies do not give any information to them.
This is considered an out of date browser. This website has been developed with modern browsers in mind to allow it to display at its best in a wide variety of viewing situations - including mobile viewing. But we haven't supported older browsers like IE8. Please upgrade to the latest version of Internet Explorer - or try Mozilla Firefox or Google Chrome. Both are excellent browsers.